130 related articles for article (PubMed ID: 20963355)
21. [Differences in clinical features between cholesteatoma in external auditory meatus and middle ear].
Wang Y; Ye Q; Wang Z; Teng B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 29(14):1268-71. PubMed ID: 26672240
[TBL] [Abstract][Full Text] [Related]
22. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
23. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
[TBL] [Abstract][Full Text] [Related]
24. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
[TBL] [Abstract][Full Text] [Related]
25. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
[TBL] [Abstract][Full Text] [Related]
26. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.
Porter RM; Reichelt J; Lunny DP; Magin TM; Lane EB
J Invest Dermatol; 1998 Jun; 110(6):951-7. PubMed ID: 9620304
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical investigations on external auditory canal cholesteatomas.
Adamczyk M; Sudhoff H; Jahnke K
Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
[TBL] [Abstract][Full Text] [Related]
28. Canine aural cholesteatoma: a histological and immunohistochemical study.
Banco B; Grieco V; Di Giancamillo M; Greci V; Travetti O; Martino P; Mortellaro CM; Giudice C
Vet J; 2014 Jun; 200(3):440-5. PubMed ID: 24775276
[TBL] [Abstract][Full Text] [Related]
29. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
[TBL] [Abstract][Full Text] [Related]
30. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
Li S; Zhan H; Peng S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
[TBL] [Abstract][Full Text] [Related]
31. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
32. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
34. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
Olszewska E; Sudhoff H
Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin expression patterns in the human tympanic membrane and external ear canal.
Lepercque S; Broekaert D; Van Cauwenberge P
Eur Arch Otorhinolaryngol; 1993; 250(2):78-81. PubMed ID: 7685180
[TBL] [Abstract][Full Text] [Related]
36. External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.
Thorsteinsson AL; Vestergaard P; Eiken P
Osteoporos Int; 2014 Jul; 25(7):1937-44. PubMed ID: 24664275
[TBL] [Abstract][Full Text] [Related]
37. Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.
Olszewska E; Lautermann J; Koc C; Schwaab M; Dazert S; Hildmann H; Sudhoff H
Eur Arch Otorhinolaryngol; 2005 Sep; 262(9):731-6. PubMed ID: 15754169
[TBL] [Abstract][Full Text] [Related]
38. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
39. [Surgical treatment of external auricular cholesteatoma involving tympanum and papilloma].
Song ZY; Yu XM; Wang CF; Wang N; Fu Y; Song YQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(12):937-940. PubMed ID: 29921078
[No Abstract] [Full Text] [Related]
40. Sometimes it takes darkness to see the light: pitfalls in the interpretation of cell proliferation markers (Ki-67 and PCNA).
Castilla C; McDonough P; Tumer G; Lambert PC; Lambert WC
Skinmed; 2012; 10(2):90-2. PubMed ID: 22545323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
